Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Roux

Showing results (471-480 of 504) with videos related to

Pageof 51
Sort By:
Oncogene|October 24, 2017
FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasisM S Chattaragada, C Riganti, M Sassoe, et al.
The Onderstepoort Journal of Veterinary Research|July 5, 2005
Claviceps cyperi, a new cause of severe ergotism in dairy cattle consuming maize silage and teff hay contaminated with ergotised Cyperus esculentus (nut sedge) on the Highveld of South AfricaT W Naudè, C J Botha, J H Vorster, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 4, 2012
Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year dataM R McClung, J R Zanchetta, A Racewicz, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 29, 2014
Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonateJ P Brown, C Roux, P R Ho, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 30, 2011
Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosisJ-Y Reginster, J-M Kaufman, S Goemaere, et al.
Carcinogenesis|September 11, 2012
Disruption of the interaction between PMCA2 and calcineurin triggers apoptosis and enhances paclitaxel-induced cytotoxicity in breast cancer cellsRhiannon R Baggott, Tamer M A Mohamed, Delvac Oceandy, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|January 15, 2011
High throughput analysis of grape genetic diversity as a tool for germplasm collection managementV Laucou, T Lacombe, F Dechesne, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 5, 2002
Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosisR Rizzoli, S L Greenspan, G Bone, et al.
Bone|October 22, 2013
Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomized open-label studyC Roux, L C Hofbauer, P R Ho, et al.
Therapie|November 7, 1998
[Toxicology of reproduction: predictive value of experimental models. Round Table No 1 at Giens XIII]P Guittin, C Soubrié, E Autret, et al.
Pageof 51

Showing results (471-480 of 504) with videos related to

Sort By:
Pageof 51
Oncogene|October 24, 2017
FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasisM S Chattaragada, C Riganti, M Sassoe, et al.
The Onderstepoort Journal of Veterinary Research|July 5, 2005
Claviceps cyperi, a new cause of severe ergotism in dairy cattle consuming maize silage and teff hay contaminated with ergotised Cyperus esculentus (nut sedge) on the Highveld of South AfricaT W Naudè, C J Botha, J H Vorster, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 4, 2012
Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year dataM R McClung, J R Zanchetta, A Racewicz, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 29, 2014
Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonateJ P Brown, C Roux, P R Ho, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 30, 2011
Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosisJ-Y Reginster, J-M Kaufman, S Goemaere, et al.
Carcinogenesis|September 11, 2012
Disruption of the interaction between PMCA2 and calcineurin triggers apoptosis and enhances paclitaxel-induced cytotoxicity in breast cancer cellsRhiannon R Baggott, Tamer M A Mohamed, Delvac Oceandy, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|January 15, 2011
High throughput analysis of grape genetic diversity as a tool for germplasm collection managementV Laucou, T Lacombe, F Dechesne, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 5, 2002
Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosisR Rizzoli, S L Greenspan, G Bone, et al.
Bone|October 22, 2013
Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomized open-label studyC Roux, L C Hofbauer, P R Ho, et al.
Therapie|November 7, 1998
[Toxicology of reproduction: predictive value of experimental models. Round Table No 1 at Giens XIII]P Guittin, C Soubrié, E Autret, et al.
Pageof 51